• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bone-independent extramedullary disease is associated with inferior overall survival in multiple myeloma patients: a single-center, real-world experience.

作者信息

Xu Ke, Agbuduwe Charles, Kanellias Nickolaos, Wilson William, McMillan Annabel, Papanikolaou Xenofon, Lee Lydia, Popat Rakesh, Sive Jonathan, Rabin Neil, Yong Kwee, Parcharidou Agapi, Kyriakou Charalampia

机构信息

University College London Hospitals NHS Trust, London.

London North West University Healthcare NHS Trust, London.

出版信息

Haematologica. 2025 May 1;110(5):1182-1186. doi: 10.3324/haematol.2024.286409. Epub 2024 Dec 5.

DOI:10.3324/haematol.2024.286409
PMID:39633554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12050924/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/219d/12050924/e2f9149d658f/1101182.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/219d/12050924/e2f9149d658f/1101182.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/219d/12050924/e2f9149d658f/1101182.fig1.jpg

相似文献

1
Bone-independent extramedullary disease is associated with inferior overall survival in multiple myeloma patients: a single-center, real-world experience.骨外非髓性疾病与多发性骨髓瘤患者较差的总生存期相关：一项单中心真实世界研究。
Haematologica. 2025 May 1;110(5):1182-1186. doi: 10.3324/haematol.2024.286409. Epub 2024 Dec 5.
2
Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse.软组织髓外多发性骨髓瘤的预后明显比骨相关髓外复发差。
Haematologica. 2014 Feb;99(2):360-4. doi: 10.3324/haematol.2013.094409. Epub 2013 Sep 13.
3
Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease.基于卡非佐米的治疗策略在伴有髓外疾病的复发/难治性多发性骨髓瘤管理中的应用
Cancers (Basel). 2020 Apr 23;12(4):1035. doi: 10.3390/cancers12041035.
4
Exploring secondary extramedullary myeloma disease: a five-predictor scoring system with spotlight on double-hit cytogenetics.探索继发性髓外骨髓瘤疾病：一种聚焦双打击细胞遗传学的五预测因子评分系统。
BMC Med. 2025 May 2;23(1):257. doi: 10.1186/s12916-025-04086-y.
5
AYA-Myeloma: Real-World, Single-Center Experience Over Last 5 Years.青少年及年轻成人多发性骨髓瘤：过去5年的真实世界单中心经验
J Adolesc Young Adult Oncol. 2018 Feb;7(1):120-124. doi: 10.1089/jayao.2017.0034. Epub 2017 Aug 22.
6
Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma.多部位髓外骨相关和/或髓外骨外病变是新诊断多发性骨髓瘤患者独立的不良预后因素。
Front Oncol. 2021 Jul 7;11:668099. doi: 10.3389/fonc.2021.668099. eCollection 2021.
7
Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.循环血清微小RNA-130a作为髓外骨髓瘤的一种新型潜在标志物
PLoS One. 2015 Sep 21;10(9):e0137294. doi: 10.1371/journal.pone.0137294. eCollection 2015.
8
Clinical Characteristics and Prognosis of Multiple Myeloma With Myelomatous Pleural Effusion: A Retrospective Single-Center Study.多发性骨髓瘤合并浆膜腔积液患者的临床特征及预后：一项回顾性单中心研究。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221132370. doi: 10.1177/15330338221132370.
9
Diff erent expression of genes involved in unfolded protein response in multiple myeloma and extramedullary dis ease patients.多发性骨髓瘤和髓外疾病患者中未折叠蛋白反应相关基因的不同表达。
Klin Onkol. 2025;38(1):45-51. doi: 10.48095/ccko202545.
10
Extramedullary disease in multiple myeloma at diagnosis and over the course of the disease.多发性骨髓瘤诊断时及疾病过程中的髓外病变
Int J Hematol. 2025 Mar 3. doi: 10.1007/s12185-025-03958-6.

引用本文的文献

1
Therapeutic options for extramedullary involvement in multiple myeloma.多发性骨髓瘤髓外浸润的治疗选择。
Clin Exp Med. 2025 Aug 23;25(1):301. doi: 10.1007/s10238-025-01821-w.
2
Beyond the bone marrow: a review of therapeutic approaches for extramedullary disease in multiple myeloma and the significance of MRD assessment.骨髓之外：多发性骨髓瘤髓外疾病的治疗方法综述及微小残留病评估的意义
J Med Life. 2025 Jun;18(6):536-544. doi: 10.25122/jml-2025-0104.

本文引用的文献

1
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma.美法仑氟芬酰胺联合地塞米松治疗复发难治性多发性骨髓瘤
N Engl J Med. 2023 Sep 14;389(11):1009-1022. doi: 10.1056/NEJMoa2303194. Epub 2023 Aug 30.
2
Clinical characteristics and outcomes of IgD myeloma: experience across UK national trials.IgD 骨髓瘤的临床特征和结局：英国国家试验中的经验。
Blood Adv. 2022 Sep 13;6(17):5113-5123. doi: 10.1182/bloodadvances.2022007608.
3
Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple Myeloma.
多次接受治疗的复发难治性多发性骨髓瘤患者的治疗选择
Clin Lymphoma Myeloma Leuk. 2022 Jul;22(7):460-473. doi: 10.1016/j.clml.2022.01.011. Epub 2022 Jan 19.
4
Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma.多部位髓外骨相关和/或髓外骨外病变是新诊断多发性骨髓瘤患者独立的不良预后因素。
Front Oncol. 2021 Jul 7;11:668099. doi: 10.3389/fonc.2021.668099. eCollection 2021.
5
Multiple myeloma.多发性骨髓瘤。
Lancet. 2021 Jan 30;397(10272):410-427. doi: 10.1016/S0140-6736(21)00135-5.
6
Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1-2 study.美法仑氟芬酰胺联合地塞米松治疗复发难治性多发性骨髓瘤（O-12-M1）：一项多中心、国际性、开放标签的1/2期研究
Lancet Haematol. 2020 May;7(5):e395-e407. doi: 10.1016/S2352-3026(20)30044-2. Epub 2020 Mar 23.
7
Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs.新诊断多发性骨髓瘤患者新药物治疗后骨旁髓外疾病的结果。
Haematologica. 2020 Jan;105(1):193-200. doi: 10.3324/haematol.2019.219139. Epub 2019 Jun 20.
8
Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT.新诊断多发性骨髓瘤患者自体干细胞移植后髓外疾病的影响：来自 EBMT 慢性恶性肿瘤工作组的研究。
Haematologica. 2018 May;103(5):890-897. doi: 10.3324/haematol.2017.178434. Epub 2018 Feb 1.
9
Cytogenetics in multiple myeloma patients progressing into extramedullary disease.进展为髓外疾病的多发性骨髓瘤患者的细胞遗传学
Eur J Haematol. 2016 Jul;97(1):93-100. doi: 10.1111/ejh.12688. Epub 2015 Oct 19.
10
Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation.接受干细胞移植患者的髓外多发性骨髓瘤的发病率及临床特征
Br J Haematol. 2015 Jun;169(6):851-8. doi: 10.1111/bjh.13383. Epub 2015 Apr 1.